Tus-Pharmaceutical Group Co., Ltd.
|
395.92 Million CNY
|
26.148%
|
Jinling Pharmaceutical Company Limited
|
2.78 Billion CNY
|
89.504%
|
Jiuzhitang Co., Ltd.
|
2.91 Billion CNY
|
89.984%
|
Huapont Life Sciences Co., Ltd.
|
11.59 Billion CNY
|
97.478%
|
Zhejiang Hisoar Pharmaceutical Co., Ltd.
|
2.17 Billion CNY
|
86.537%
|
Shandong Wohua Pharmaceutical Co., Ltd.
|
894.31 Million CNY
|
67.305%
|
Jinhe Biotechnology CO., LTD.
|
2.17 Billion CNY
|
86.551%
|
Teyi Pharmaceutical Group Co.,Ltd
|
1.06 Billion CNY
|
72.602%
|
Kunming Longjin Pharmaceutical Co., Ltd.
|
86.62 Million CNY
|
-237.553%
|
Beijing Aosaikang Pharmaceutical Co., Ltd.
|
1.44 Billion CNY
|
79.743%
|
Chengdu Kanghong Pharmaceutical Group Co., Ltd
|
3.95 Billion CNY
|
92.611%
|
Anhui Huangshan Capsule Co., Ltd.
|
458.36 Million CNY
|
36.209%
|
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
|
980.82 Million CNY
|
70.189%
|
Shanxi Zhendong Pharmaceutical Co.,Ltd
|
3.62 Billion CNY
|
91.936%
|
Beijing Science Sun Pharmaceutical Co., Ltd.
|
476.56 Million CNY
|
38.645%
|
Wuhan Hiteck Biological Pharma Co.,Ltd
|
602.28 Million CNY
|
51.452%
|
Dong-E-E-Jiao Co.,Ltd.
|
4.71 Billion CNY
|
93.799%
|
Zhejiang Garden Bio-chemical High-tech Co., Ltd.
|
1.09 Billion CNY
|
73.289%
|
Fujian Cosunter Pharmaceutical Co., Ltd.
|
422.71 Million CNY
|
30.829%
|
Jinghua Pharmaceutical Group Co., Ltd.
|
1.49 Billion CNY
|
80.382%
|
Hainan Haiyao Co., Ltd.
|
1.45 Billion CNY
|
79.935%
|
Dezhan Healthcare Company Limited
|
498.08 Million CNY
|
41.296%
|
Shenzhen Neptunus Bioengineering Co., Ltd.
|
36.41 Billion CNY
|
99.197%
|
Anhui Fengyuan Pharmaceutical Co., Ltd.
|
4.27 Billion CNY
|
93.161%
|
Livzon Pharmaceutical Group Inc.
|
12.27 Billion CNY
|
97.619%
|
Jilin Aodong Pharmaceutical Group Co., Ltd.
|
3.44 Billion CNY
|
91.523%
|
Changchun High-Tech Industries (Group) Inc.
|
14.46 Billion CNY
|
97.978%
|
Apeloa Pharmaceutical Co.,Ltd
|
11.47 Billion CNY
|
97.452%
|
Shandong Xinhua Pharmaceutical Company Limited
|
8 Billion CNY
|
96.349%
|
PKU HealthCare Corp.,Ltd.
|
2.19 Billion CNY
|
86.672%
|
Chengdu Huasun Technology Group Inc., Ltd.
|
1 Billion CNY
|
70.859%
|
Zhejiang Jingxin Pharmaceutical Co., Ltd.
|
3.95 Billion CNY
|
92.601%
|
Hengkang Medical Group Co., Ltd.
|
3.59 Billion CNY
|
91.856%
|
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
|
2.61 Billion CNY
|
88.799%
|
Qianjiang Yongan Pharmaceutical Co., Ltd.
|
962.8 Million CNY
|
69.631%
|
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
|
5.42 Billion CNY
|
94.607%
|
LanZhou Foci Pharmaceutical Co.,Ltd.
|
1.16 Billion CNY
|
74.861%
|
Zhuhai Rundu Pharmaceutical Co., Ltd.
|
1.29 Billion CNY
|
77.367%
|
Huaren Pharmaceutical Co., Ltd.
|
1.63 Billion CNY
|
82.13%
|
Tianjin Ringpu Bio-Technology Co.,Ltd.
|
2.24 Billion CNY
|
86.999%
|
Fuan Pharmaceutical (Group) Co., Ltd.
|
2.64 Billion CNY
|
88.957%
|
Hybio Pharmaceutical Co., Ltd.
|
431.38 Million CNY
|
32.219%
|
Baotou Dongbao Bio-Tech Co.,Ltd
|
974.51 Million CNY
|
69.996%
|
Hunan Er-Kang Pharmaceutical Co., Ltd
|
1.76 Billion CNY
|
83.473%
|
Changjiang Pharmaceutical Group Co., Ltd.
|
1.19 Billion CNY
|
75.584%
|
Zhejiang Xinguang Pharmaceutical Co., Ltd.
|
270.39 Million CNY
|
-8.135%
|
Hainan Poly Pharm. Co., Ltd
|
1.3 Billion CNY
|
77.585%
|
Jiangxi Synergy Pharmaceutical Co., Ltd.
|
722.13 Million CNY
|
59.51%
|
Zhejiang Tianyu Pharmaceutical Co., Ltd.
|
2.52 Billion CNY
|
88.43%
|
PharmaBlock Sciences (Nanjing), Inc.
|
1.72 Billion CNY
|
83.051%
|
Betta Pharmaceuticals Co., Ltd.
|
2.45 Billion CNY
|
88.096%
|
Tibet AIM Pharm. Inc.
|
667.03 Million CNY
|
56.165%
|
Shenzhen Kangtai Biological Products Co., Ltd.
|
3.47 Billion CNY
|
91.592%
|
Shandong Shanda Wit Science and Technology Co., Ltd.
|
2.48 Billion CNY
|
88.23%
|
Pacific Shuanglin Bio-pharmacy Co., LTD
|
2.32 Billion CNY
|
87.444%
|
Zhejiang AngLiKang Pharmaceutical CO.,LTD.
|
1.62 Billion CNY
|
82.016%
|
Xiamen Kingdomway Group Company
|
3.1 Billion CNY
|
90.576%
|
ShanXi C&Y Pharmaceutical Group Co., Ltd.
|
799.3 Million CNY
|
63.419%
|
Walvax Biotechnology Co., Ltd.
|
4.11 Billion CNY
|
92.892%
|
Sunflower Pharmaceutical Group Co.,Ltd
|
5.63 Billion CNY
|
94.808%
|
Harbin Gloria Pharmaceuticals Co., Ltd
|
2.58 Billion CNY
|
88.71%
|
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
|
24.73 Billion CNY
|
98.818%
|
Hunan Hansen Pharmaceutical Co., Ltd.
|
955.53 Million CNY
|
69.4%
|
Changzhou Qianhong Biopharma CO.,LTD
|
1.79 Billion CNY
|
83.7%
|
Shenzhen Weiguang Biological Products Co., Ltd.
|
1.04 Billion CNY
|
72.113%
|
Honz Pharmaceutical Co., Ltd.
|
739.56 Million CNY
|
60.464%
|
Northeast Pharmaceutical Group Co., Ltd.
|
8.16 Billion CNY
|
96.417%
|
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd
|
1.46 Billion CNY
|
80.009%
|
Guizhou Xinbang Pharmaceutical Co., Ltd.
|
6.46 Billion CNY
|
95.474%
|
Tianjin Lisheng Pharmaceutical Co.,Ltd.
|
1.13 Billion CNY
|
74.128%
|
Zhejiang Yatai Pharmaceutical Co., Ltd.
|
420.64 Million CNY
|
30.488%
|
Zhejiang NHU Company Ltd.
|
15.11 Billion CNY
|
98.066%
|
ApicHope Pharmaceutical Co., Ltd
|
2.5 Billion CNY
|
88.32%
|
Shanghai Kaibao Pharmaceutical CO.,Ltd
|
1.59 Billion CNY
|
81.657%
|
Beijing SL Pharmaceutical Co., Ltd.
|
1.01 Billion CNY
|
71.287%
|
Yunnan Baiyao Group Co.,Ltd
|
38.9 Billion CNY
|
99.248%
|
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD
|
1.08 Billion CNY
|
72.927%
|
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.
|
839.25 Million CNY
|
65.16%
|
Huadong Medicine Co., Ltd
|
40.39 Billion CNY
|
99.276%
|
Jiangsu Nhwa Pharmaceutical Co., LTD
|
4.97 Billion CNY
|
94.121%
|
Harbin Medisan Pharmaceutical Co., Ltd.
|
1.18 Billion CNY
|
75.362%
|
Tianjin Chase Sun Pharmaceutical Co.,Ltd
|
6.12 Billion CNY
|
95.228%
|
Beijing Beilu Pharmaceutical Co., Ltd
|
890.71 Million CNY
|
67.173%
|
Nanjing Hicin Pharmaceutical Co., Ltd.
|
517.83 Million CNY
|
43.534%
|
Renhe Pharmacy Co., Ltd.
|
5.03 Billion CNY
|
94.189%
|
Chongqing Pharscin Pharmaceutical Co., Ltd.
|
691.54 Million CNY
|
57.718%
|
Zhejiang Xianju Pharmaceutical Co.,Ltd.
|
4.12 Billion CNY
|
92.909%
|
Luoxin Pharmaceuticals Group Stock Co., Ltd.
|
2.34 Billion CNY
|
87.518%
|
Guizhou Bailing Group Pharmaceutical Co., Ltd.
|
4.26 Billion CNY
|
93.141%
|